GC메디아이

032620KOSDAQ소프트웨어 개발 및 공급업

60.9 / 100

Reference Date: 2026-06-10

Financial Score27.5 / 40

News Sentiment19.4 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Plunged 21.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

UbiCare operates four business segments: EMR solutions, distribution, pharmaceutical data, and manufacturing. It supports the digital transformation of hospitals and pharmacies through its extensive network, holding the highest market share in the EMR sector. The company builds a digital healthcare ecosystem based on EMR platforms, data analytics, and distribution services.

Number of Employees

279people

Average Salary

62.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

4.26Industry Average 13.628.0Point

Half of industry avg (excellent)

PBR

1.02Industry Average 1.024.0Point

In line with industry avg

ROE

28.37Industry Average 1.107.0Point

25.8x industry avg (excellent)

Debt Ratio

20.69Industry Average 7.930.0Point

2.6x industry avg (risky)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲46.4% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.7% (improving, 3yr)

Detailed News Sentiment

6 totalPositive 5Neutral 1Negative 0Average Sentiment Score 77.5

Neutral
“무료 청구 있는데 왜 돈 내나”…실손24 확산 막는 EMR·인슈어테크
GC메디아이 관련 직접적인 영향 없음, 주로 EMR 및 인슈어테크 분야의 실손보험 청구 관련 이슈 언급.
Positive
GC메디아이 "일반의약품 분석 통합솔루션 'UBIST OTC' 출시"
GC메디아이의 신규 OTC 분석 솔루션 출시로 제약업계 내 시장 분석 능력 강화 및 경쟁력 향상 기대.
Positive
'실손24 거부' 철퇴… 정부, EMR업체 담합조사 등 칼 뺐다
정부의 EMR 업체 담합 조사 강화로 GC메디아이의 시장 지위에 긍정적 영향 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 3,090Won52-week high 4,33052-week low 3,090

1-month return0.0Point

1m -21.17% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-20
Neutral주식등의대량보유상황보고서(일반)2026-05-20
Neutral기업설명회(IR)개최2026-05-19
Neutral분기보고서 (2026.03)2026-05-15